phenotypic screening

Aluda Pharmaceuticals is a drug discovery company focused on novel targets for complex diseases, particularly immune and fibrotic diseases. It designs new drug molecules using tools including CRISPR, proteomic array analysis, genetics, molecular medicine, cell biology, big data, and chemical design, and pioneered proprietary concepts in phenotypic screening. Its lead program is a first-in-class anti-vimentin program for fibrosis.

big datacell biologychemical designCRISPRdrug discoverygeneticsmolecular medicineproteomic array analysis

Eigen Therapeutics is a biotechnology company developing therapies that make cancer easier to find and eliminate. It focuses on 'priming' co-therapies that modulate the expression of targets to mark cancer cells and unmark healthy cells, addressing tumor heterogeneity to help targeted therapies reach their full potential. Its discovery engine uses machine learning, automation, robotics, and high-throughput phenotypic screening.

automated laboratoryco-therapy discoveryhigh-throughput combinatorial screeninglab operations softwaremachine learningrobotic workcells

iLABS provides an AI-driven platform that turns microscopy image stacks into biological readouts, automating in vitro analytical workflows for biotech, pharma, and life science research. The platform offers AI segmentation and tracking, GPU batch processing, and assay-ready readouts packaged as CSV, JSON, and PDF reports. It is SOC 2 Type II certified and HIPAA-ready.

AI segmentation & trackingAPIbatch processingcell trackingGPU batch processingmorphology characterizationreproducible pipelinestoxicity measurement